China's Weiling Medical raises over 100M yuan for medical brain-computer interface
What's the deal? Shenzhen Weiling Medical Technology, a company developing medical brain-computer interfaces (BCI), has raised more than 100 million yuan (about $14.8 million). Junzheng CapitalDealroom has a profile for this one. Try Dealroom → led the round, with LG InnotekDealroom has a profile for this one. Try Dealroom → acting as the fund's core industrial investor.
Where the money goes: The funds will back clinical verification of its core implantable BCI products, speed up medical-device registration, build out manufacturing, and expand clinical applications in neurological repair.
Why now? Founded in 2019, Weiling develops implantable BCI products aimed at neurological function repair. Founder Li XiaojianDealroom has a profile for this one. Try Dealroom → has spent two decades researching brain function analysis and disease intervention. The company is focusing on clinical applications for serious neurological conditions rather than consumer human-computer interaction.
Read more: 36Kr
Image credit: Jacobs School of Engineering
